Head-to-Head

Halozyme Therapeutics, Inc. vs. Krystal Biotech, Inc. Common Stock

HALO

Halozyme Therapeutics, Inc.

$91.35 -1.82%

VS KRYS

Krystal Biotech, Inc. Common Stock

$308.89 -2.19%

Halozyme Therapeutics, Inc. and Krystal Biotech, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

HALOKRYS
Market Cap $10.41 billion $9.15 billion

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

HALOKRYS
Short Interest 9.75% 0.11%

KRYS leads on 1 of 1 risk & sentiment factors.

Dig deeper: HALO overview, HALO financials, KRYS overview, KRYS financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.